IMIC(SZ:000516)2021-10-27 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥742,242,389.17, representing a 71.71% increase compared to the same period last year[2]. - The net profit attributable to shareholders was -¥225,030,976.63, a decrease of 45.78% year-on-year[2]. - The company's basic earnings per share for the period was -¥0.0992, down 23.92% year-on-year[2]. - Total operating revenue for the current period reached ¥2,048,599,881.24, a significant increase from ¥1,072,331,382.09 in the previous period, representing an increase of approximately 91%[13]. - The net profit for the current period was a loss of ¥594,151,455.04, compared to a loss of ¥506,276,161.23 in the previous period, reflecting a worsening of approximately 17%[14]. - The total comprehensive income for the current period was -¥594,151,455.04, compared to -¥506,241,411.23 in the previous period, reflecting a decrease of around 17%[15]. Cash Flow - The net cash flow from operating activities increased by 191.96% year-to-date, amounting to ¥159,391,376.23[5]. - The total cash inflow from operating activities was ¥2,020,162,719.64, compared to ¥1,179,420,093.94 in the previous period, marking an increase of around 71%[16]. - The company received cash related to other operating activities amounting to ¥139,073,798.19, down from ¥187,772,897.06 in the previous period, indicating a decrease of approximately 26%[16]. - The total cash outflow from operating activities was 1,860,771,343.41 CNY, compared to 1,352,755,581.45 CNY in the same period last year[17]. - Cash inflow from financing activities reached 2,120,819,899.01 CNY, up from 1,316,593,426.70 CNY in the same quarter last year[18]. - The net cash flow from financing activities was 1,389,095,808.94 CNY, an increase from 940,100,478.30 CNY year-over-year[18]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥12,999,051,810.25, reflecting a 7.21% increase from the end of the previous year[3]. - The company's total liabilities stood at CNY 7,279,794,597.05, compared to CNY 7,091,134,274.54 in the previous year, reflecting an increase of approximately 2.7%[11]. - The equity attributable to shareholders of the parent company rose to CNY 5,699,555,187.73 from CNY 5,000,813,442.21, indicating a growth of around 13.9%[12]. - The company's cash and cash equivalents decreased to CNY 736,121,233.53 from CNY 1,036,746,764.16 year-over-year, representing a decline of approximately 29.0%[9]. - The company's short-term borrowings decreased to CNY 263,197,645.21 from CNY 410,332,748.96, a reduction of about 35.8%[11]. - The company's long-term borrowings increased to CNY 4,330,211,540.26 from CNY 3,905,874,613.61, reflecting an increase of approximately 10.9%[11]. Investments - The company's investment income increased by 239.62% year-to-date, driven by higher returns from joint ventures[5]. - The company's long-term equity investments surged by 879.00% compared to the previous year-end, due to new investments in joint ventures[4]. - Cash inflow from investment activities totaled 2,641,357,872.76 CNY, significantly higher than 1,051,616,542.71 CNY in the previous year[17]. - The net cash flow from investment activities was -1,773,027,077.45 CNY, worsening from -1,234,742,035.15 CNY year-over-year[17]. - The company reported a cash outflow of 4,414,384,950.21 CNY from investment activities, up from 2,286,358,577.86 CNY year-over-year[17]. Operating Costs and Expenses - The company's operating costs increased by 64.20% year-to-date, in line with revenue growth[5]. - Total operating costs for the current period were ¥2,553,360,139.15, up from ¥1,584,772,444.57 in the previous period, indicating an increase of about 61%[13]. - Research and development expenses increased to ¥7,511,041.98 from ¥5,553,968.80, representing an increase of approximately 35%[13]. - Financial expenses for the current period were ¥119,817,441.59, up from ¥100,660,082.69, which is an increase of about 19%[13]. - The company reported an operating profit of -¥573,099,834.99, compared to -¥499,954,291.56 in the previous period, indicating a decline of approximately 15%[14]. Accounts Receivable and Inventory - The company reported a significant increase in accounts receivable, which rose by 69.59% compared to the previous year-end, primarily due to increased medical fees from subsidiaries[4]. - The accounts receivable increased significantly to CNY 441,152,966.55 from CNY 260,127,749.73, marking a growth of about 69.5%[9]. - The company's inventory increased to CNY 83,886,892.84 from CNY 57,445,774.17, representing a rise of approximately 46.2%[10]. Other Financial Metrics - The company paid 848,032,985.04 CNY to employees, an increase from 656,073,997.72 CNY in the previous year[17]. - The company reported a decrease in undistributed profits to CNY 2,056,393,902.86 from CNY 2,641,312,562.87, a decline of approximately 22.1%[12]. - The total current liabilities decreased to CNY 2,905,185,639.18 from CNY 3,140,931,434.33, a decline of about 7.5%[11]. - The company did not adjust the balance sheet items at the beginning of the year under the new leasing standards, as it did not involve any adjustments[19].